UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Clinical journal of the American Society of Nephrology, 2010-08, Vol.5 (8), p.1394-1400

2010

Volltextzugriff (PDF)

Contaminated Cocaine and Antineutrophil Cytoplasmic Antibody-Associated Disease

Clinical journal of the American Society of Nephrology, 2011-12, Vol.6 (12), p.2799-2805

2011

Volltextzugriff (PDF)

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Circulation (New York, N.Y.), 2009-05, Vol.119 (19), p.2545-2552

2009

Volltextzugriff (PDF)

Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial

Annals of the rheumatic diseases, 2024-03, Vol.83 (3), p.351-359

2024

Volltextzugriff (PDF)

Incidence, Clinical Features, and Outcomes of Late‐Onset Neutropenia From Rituximab for Autoimmune Disease

Arthritis & rheumatology (Hoboken, N.J.), 2021-02, Vol.73 (2), p.347-354

2021

Volltextzugriff (PDF)

Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis

Clinical journal of the American Society of Nephrology, 2014-04, Vol.9 (4), p.736-744

2014

Volltextzugriff (PDF)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney international reports, 2018-03, Vol.3 (2), p.394-402

2018

Volltextzugriff (PDF)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab

Kidney international reports, 2020-04, Vol.5 (4), p.542-545

2020

Volltextzugriff (PDF)

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders

BMC women's health, 2021-08, Vol.21 (1), p.1-285, Article 285

2021

Volltextzugriff (PDF)

Fetal outcomes after rituximab exposure in women with autoimmune vasculitis

Annals of the rheumatic diseases, 2013-12, Vol.72 (12), p.2051-2053

2013

Volltextzugriff (PDF)

Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD

American journal of kidney diseases, 2013-01, Vol.61 (1), p.67-73

2013

Volltextzugriff (PDF)

Efficacy of Rituximab in Long-Term Maintenance of Remission in Lupus Nephritis: SA-PO880

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.972-972

2023

Volltextzugriff (PDF)

Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Based on B Cell Reconstitution vs. a Serologic ANCA Flare (MAINTANCAVAS): PO1422

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.450-450

2021

Volltextzugriff (PDF)

Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up

American journal of kidney diseases, 2021-12, Vol.78 (6), p.793-803

2021

Volltextzugriff (PDF)

Anticoagulation Thromboprophylaxis Is More Effective than Antiplatelet Thromboprophylaxis for Individuals with High-Risk Membranous Nephropathy: SA-PO915

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.983-984

2023

Volltextzugriff (PDF)

Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis: PO1730

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.542-543

2020

Volltextzugriff (PDF)

Effect of COVID-19 Infection in Three Patients Treated with Rituximab: PUB069

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.812-812

2020

Volltextzugriff (PDF)

Rituximab as Maintenance Therapy in Lupus Nephritis: PO1914

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.593-593

2020

Volltextzugriff (PDF)

Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Arthritis & rheumatology (Hoboken, N.J.), 2017-05, Vol.69 (5), p.1045-1053

2017

Volltextzugriff (PDF)

Fibrillary Glomerulonephritis: A Case Series with Clinical Features and Outcomes: PO1859

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.578-579

2020

Volltextzugriff (PDF)

314. MATERNOFETAL OUTCOMES IN PREGNANCIES WITH GESTATIONAL RITUXIMAB EXPOSURE

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Volltextzugriff (PDF)

364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Volltextzugriff (PDF)

T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19

Science translational medicine, 2023-11, Vol.15 (724), p.eadh4529

2023

Volltextzugriff (PDF)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome

Clinical Kidney Journal, 2019-04, Vol.12 (2), p.224-231

2019

Volltextzugriff (PDF)

The effect of continuous B cell depletion with rituximab on pathogenic autoantibodies and total IgG levels in ANCA vasculitis

Arthritis & rheumatology (Hoboken, N.J.), 2017-03, Vol.69 (5), p.1045-1053

2017

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(46)
Berichte
(2)
Bücher
(1)

Sprache

Englisch
(49)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(21)
Female
(15)
Male
(13)
Rituximab
(11)
Urology & Nephrology
(10)
Aged
(9)
Middle Aged
(9)
Adult
(8)
Retrospective Studies
(7)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Drug Therapy
(6)
Patients
(6)
Rheumatology
(6)
Treatment Outcome
(6)
Recurrence
(5)
Remission
(5)
Risk Factors
(5)
Autoimmune Diseases
(4)
Cyclophosphamide
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Contaminated Cocaine and Antineutrophil Cytoplasmic Antibody-Associated Disease

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial

Incidence, Clinical Features, and Outcomes of Late‐Onset Neutropenia From Rituximab for Autoimmune Disease

Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders

Fetal outcomes after rituximab exposure in women with autoimmune vasculitis

Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD

Efficacy of Rituximab in Long-Term Maintenance of Remission in Lupus Nephritis: SA-PO880

Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Based on B Cell Reconstitution vs. a Serologic ANCA Flare (MAINTANCAVAS): PO1422

Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up

Anticoagulation Thromboprophylaxis Is More Effective than Antiplatelet Thromboprophylaxis for Individuals with High-Risk Membranous Nephropathy: SA-PO915

Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis: PO1730

Effect of COVID-19 Infection in Three Patients Treated with Rituximab: PUB069

Rituximab as Maintenance Therapy in Lupus Nephritis: PO1914

Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Fibrillary Glomerulonephritis: A Case Series with Clinical Features and Outcomes: PO1859

314. MATERNOFETAL OUTCOMES IN PREGNANCIES WITH GESTATIONAL RITUXIMAB EXPOSURE

364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT

T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome

The effect of continuous B cell depletion with rituximab on pathogenic autoantibodies and total IgG levels in ANCA vasculitis

Suchergebnisse filtern